ICOA
AZN icon

Investment Centers of America’s AstraZeneca AZN Stock Holding History

Investment Centers of America’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,128
Closed -$225K – 640
2016
Q4 		$225K Buy
+4,128
New +$234K 0.02% 523

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Investment Centers of America's AZN Position: Q1 2017 in Review

Investment Centers of America sold out of AstraZeneca (AZN) in Q1 2017, closing a stake of 4,128 shares — an estimated $225K sold.

Investment Centers of America first reported a position in AZN in Q4 2016 and held it in 1 quarter. The position peaked at $225K in Q4 2016. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • Investment Centers of America reported no remaining AstraZeneca position as of Q1 2017 after selling out during the quarter.
  • Investment Centers of America sold 4,128 AstraZeneca shares in Q1 2017, an estimated $225K.
  • Investment Centers of America first reported a position in AstraZeneca in Q4 2016 and held it in 1 quarter.
  • Investment Centers of America's AstraZeneca position peaked at $225K in Q4 2016.
  • 461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Investment Centers of America's 13F filing for Q1 2017, filed 15 May 2017.